Literature DB >> 20553924

La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic.

Samantha S Soldan1, Bradley S Hollidge, Valentina Wagner, Friedemann Weber, Francisco González-Scarano.   

Abstract

La Crosse virus is a leading cause of pediatric encephalitis in the Midwestern United States and an emerging pathogen in the American South. The LACV glycoprotein Gc plays a critical role in entry as the virus attachment protein. A 22 amino acid hydrophobic region within Gc (1066-1087) was recently identified as the LACV fusion peptide. To further define the role of Gc (1066-1087) in virus entry, fusion, and neuropathogenesis, a panel of recombinant LACV (rLACV) fusion peptide mutant viruses was generated. Replication of mutant rLACVs was significantly reduced. In addition, the fusion peptide mutants demonstrated decreased fusion phenotypes relative to LACV-WT. Interestingly, these viruses maintained their ability to cause neuronal loss in culture, suggesting that the fusion peptide of LACV Gc is a determinant of properties associated with neuroinvasion (growth to high titer in muscle cells and a robust fusion phenotype), but not necessarily of neurovirulence. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20553924      PMCID: PMC2919166          DOI: 10.1016/j.virol.2010.04.012

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  34 in total

1.  A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus.

Authors:  D R Sundin; B J Beaty; N Nathanson; F Gonzalez-Scarano
Journal:  Science       Date:  1987-01-30       Impact factor: 47.728

2.  Virulence of La Crosse virus is under polygenic control.

Authors:  R S Janssen; N Nathanson; M J Endres; F Gonzalez-Scarano
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

3.  Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus.

Authors:  R Janssen; F Gonzalez-Scarano; N Nathanson
Journal:  Lab Invest       Date:  1984-04       Impact factor: 5.662

4.  La Crosse virus G1 glycoprotein undergoes a conformational change at the pH of fusion.

Authors:  F Gonzalez-Scarano
Journal:  Virology       Date:  1985-01-30       Impact factor: 3.616

5.  An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function.

Authors:  F Gonzalez-Scarano; R S Janssen; J A Najjar; N Pobjecky; N Nathanson
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

6.  La Crosse bunyavirus can mediate pH-dependent fusion from without.

Authors:  F Gonzalez-Scarano; N Pobjecky; N Nathanson
Journal:  Virology       Date:  1984-01-15       Impact factor: 3.616

7.  Analyses of the mRNA transcription processes of snowshoe hare bunyavirus S and M RNA species.

Authors:  Y Eshita; B Ericson; V Romanowski; D H Bishop
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

8.  Characterization of monoclonal antibodies against the G1 and N proteins of LaCrosse and Tahyna, two California serogroup bunyaviruses.

Authors:  F Gonzalez-Scarano; R E Shope; C E Calisher; N Nathanson
Journal:  Virology       Date:  1982-07-15       Impact factor: 3.616

9.  Functional L polymerase of La Crosse virus allows in vivo reconstitution of recombinant nucleocapsids.

Authors:  Gjon Blakqori; Georg Kochs; Otto Haller; Friedemann Weber
Journal:  J Gen Virol       Date:  2003-05       Impact factor: 3.891

10.  Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses.

Authors:  Matthias Habjan; Nicola Penski; Valentina Wagner; Martin Spiegel; Anna K Overby; Georg Kochs; Juha T Huiskonen; Friedemann Weber
Journal:  Virology       Date:  2009-01-19       Impact factor: 3.616

View more
  12 in total

1.  Development of Antiviral Innate Immunity During In Vitro Differentiation of Mouse Embryonic Stem Cells.

Authors:  William D'Angelo; Dhiraj Acharya; Ruoxing Wang; Jundi Wang; Chandan Gurung; Bohan Chen; Fengwei Bai; Yan-Lin Guo
Journal:  Stem Cells Dev       Date:  2016-03-17       Impact factor: 3.272

2.  Orthobunyavirus entry into neurons and other mammalian cells occurs via clathrin-mediated endocytosis and requires trafficking into early endosomes.

Authors:  Bradley S Hollidge; Natalia B Nedelsky; Mary-Virginia Salzano; Jonathan W Fraser; Francisco González-Scarano; Samantha S Soldan
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  Antiviral responses in mouse embryonic stem cells: differential development of cellular mechanisms in type I interferon production and response.

Authors:  Ruoxing Wang; Jundi Wang; Dhiraj Acharya; Amber M Paul; Fengwei Bai; Faqing Huang; Yan-Lin Guo
Journal:  J Biol Chem       Date:  2014-06-25       Impact factor: 5.157

4.  The Orthobunyavirus Germiston Enters Host Cells from Late Endosomes.

Authors:  Stefan Windhaber; Qilin Xin; Zina M Uckeley; Jana Koch; Martin Obr; Céline Garnier; Catherine Luengo-Guyonnot; Maëva Duboeuf; Florian K M Schur; Pierre-Yves Lozach
Journal:  J Virol       Date:  2022-01-12       Impact factor: 6.549

5.  Mouse embryonic stem cells are deficient in type I interferon expression in response to viral infections and double-stranded RNA.

Authors:  Ruoxing Wang; Jundi Wang; Amber M Paul; Dhiraj Acharya; Fengwei Bai; Faqing Huang; Yan-Lin Guo
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

6.  Systems to establish bunyavirus genome replication in the absence of transcription.

Authors:  Carolin Klemm; Juan Reguera; Stephen Cusack; Florian Zielecki; Georg Kochs; Friedemann Weber
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

Review 7.  Arboviral encephalitides: transmission, emergence, and pathogenesis.

Authors:  Bradley S Hollidge; Francisco González-Scarano; Samantha S Soldan
Journal:  J Neuroimmune Pharmacol       Date:  2010-07-22       Impact factor: 7.285

8.  An assembly model of rift valley Fever virus.

Authors:  Mirabela Rusu; Richard Bonneau; Michael R Holbrook; Stanley J Watowich; Stefan Birmanns; Willy Wriggers; Alexander N Freiberg
Journal:  Front Microbiol       Date:  2012-07-19       Impact factor: 5.640

Review 9.  Early Bunyavirus-Host Cell Interactions.

Authors:  Amelina Albornoz; Anja B Hoffmann; Pierre-Yves Lozach; Nicole D Tischler
Journal:  Viruses       Date:  2016-05-24       Impact factor: 5.048

10.  Human neural stem cell-derived neuron/astrocyte co-cultures respond to La Crosse virus infection with proinflammatory cytokines and chemokines.

Authors:  Brian E Dawes; Junling Gao; Colm Atkins; Jacob T Nelson; Kendra Johnson; Ping Wu; Alexander N Freiberg
Journal:  J Neuroinflammation       Date:  2018-11-15       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.